Correction: Charting the Clinical Landscape of Lenvatinib-Integrated Therapies for Hepatocellular Carcinoma

Affiliations

¹ North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
² Department of Hepato-Biliary-Pancrease II, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
³ Department of Orthopedics, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, Shandong Province, China. geng.tianxiang@outlook.com.
⁴ Department of General Surgery, and Institute of Hepato-Biliary-Pancreas and Intestinal Disease, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. xiejiebin84@126.com.

Published Erratum

Jinxin Yu et al. Ann Surg Oncol. 2025 Oct.

. 2025 Oct;32(10):7679.

doi: 10.1245/s10434-025-18151-6.

¹ North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
² Department of Hepato-Biliary-Pancrease II, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
³ Department of Orthopedics, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, Shandong Province, China. geng.tianxiang@outlook.com.
⁴ Department of General Surgery, and Institute of Hepato-Biliary-Pancreas and Intestinal Disease, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. xiejiebin84@126.com.

No abstract available

Erratum for

Charting the Clinical Landscape of Lenvatinib-Integrated Therapies for Hepatocellular Carcinoma.
Yu J, Yu J, Luo Z, Xian J, Li K, Geng T, Xie J. Yu J, et al. Ann Surg Oncol. 2025 Oct;32(10):7121-7123. doi: 10.1245/s10434-025-17778-9. Epub 2025 Jul 7. Ann Surg Oncol. 2025. PMID: 40622563 No abstract available.